PAPER Imhoff D, Sturzenegger R, Went P, Pantazis G

[Two Different Courses of a Rare, Potentially Reversible Encephalopathy].

Praxis (Bern 1994). 2025 Feb;114(2):66-71. PubMed.

PAPER Forrest SL, Sadia N, Khodadadi M, Tator C, Green R, Tartaglia MC, Kovacs GG

Unprecedented Combination of Rare Degenerative Pathologies in an Octogenarian Ex-Football Player.

Neuropathology. 2025 Mar 13; Epub 2025 Mar 13 PubMed.

PAPER Nakase T, Tatewaki Y, Takano Y, Nomura S, Baek HW, Taki Y

Blood Biomarkers Reflect Dementia Symptoms and Are Influenced by Cerebrovascular Lesions.

Int J Mol Sci. 2025 Mar 5;26(5) PubMed.

PAPER Grimaldi L, Cavallaro RA, De Angelis D, Fuso A, Sancesario G

Vitamin K Properties in Stroke and Alzheimer's Disease: A Janus Bifrons in Protection and Prevention.

Molecules. 2025 Feb 24;30(5) PubMed.

PAPER Kakino Y, Hattori Y, Ogata S, Nakaoku Y, Nishimura K, Iida H, Ihara M

Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion.

J Am Heart Assoc. 2025 Mar 13;:e039210. Epub 2025 Mar 13 PubMed.

PAPER Pang S, Li Z, Liu A, Luo ZH, Yin H, Fan S, Shi J, Liu N, Pan S, Yang YJ, Zhang GJ, Chen J

A Novel Oxo-Palmatine Derivative 2q as Potent Reversal Agents Against Alzheimer's Disease.

Drug Dev Res. 2025 Apr;86(2):e70073. PubMed.

PAPER Guo H, Yang R, Cheng W, Li Q, Du M

An Update of Salivary Biomarkers for the Diagnosis of Alzheimer's Disease.

Int J Mol Sci. 2025 Feb 26;26(5) PubMed.

PAPER Michielsen A, van Veenhuijzen K, Hiemstra F, Jansen IM, Kalkhoven B, Veldink JH, Kruitwagen ET, van Es M, van Zandvoort MJ, van den Berg LH, Westeneng HJ

Cognitive impairment within and beyond the FTD spectrum in ALS: development of a complementary cognitive screen.

J Neurol. 2025 Mar 13;272(4):268. PubMed.

PAPER Alves L, Hashiguchi D, Loss CM, van Praag H, Longo BM

Vascular dysfunction in Alzheimer's disease: Exploring the potential of aerobic and resistance exercises as therapeutic strategies.

J Alzheimers Dis. 2025 Mar 13;:13872877251321118. Epub 2025 Mar 13 PubMed.

PAPER Nie P, Wu Y, Robinson J, Mekala S, Lee VM, Li YM

In Situ Labeling of Pathogenic Tau Using Photo-Affinity Chemical Probes.

ACS Chem Biol. 2025 Mar 13; Epub 2025 Mar 13 PubMed.

PAPER Zhu Q, Deng YL, Liu Y, Steenland K

Associations between Ultrafine Particles and Incident Dementia in Older Adults.

Environ Sci Technol. 2025 Mar 13; Epub 2025 Mar 13 PubMed.

PAPER Frydas A, Cacace R, van der Zee J, Van Broeckhoven C, Wauters E

Investigation of the role of miRNA variants in neurodegenerative brain diseases.

Front Genet. 2025;16:1506169. Epub 2025 Feb 26 PubMed.

PAPER Gupta C, Kim C, Guzy S, Yoneyama T, Gharahi H, Siripuram VK, Iadevaia S, Barua D, Hang Y, Iakovleva T, Boucher C, Vakilynejad M, Schmidt S, Vozmediano V

Establishment of a Biomarker-Directed Clinical Endpoint Model for Early-Stage Parkinson's Disease Patients.

Clin Pharmacol Ther. 2025 Mar 12; Epub 2025 Mar 12 PubMed.

PAPER Pounds O, Theodore K, Dodd K

Factors Associated With Alzheimer's Dementia Diagnosis and Survival in Down Syndrome.

J Intellect Disabil Res. 2025 Mar 12; Epub 2025 Mar 12 PubMed.

PAPER Trojan E, Frydrych J, Lasoń W, Basta-Kaim A

Prenatal Stress Increases the Risk of the FPR2-related Dysfunction in the Brain's Resolution of Inflammation: A Study on the Humanized APPNL-F/NL-F Mouse Model of Alzheimer's Disease.

Curr Neuropharmacol. 2025 Mar 12; Epub 2025 Mar 12 PubMed.